• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌肽二级结构特征的理论分析。

A theoretical analysis of secondary structural characteristics of anticancer peptides.

机构信息

School of Pharmacy and Pharmaceutical Science, University of Central Lancashire, Preston, PR1-2HE, UK.

出版信息

Mol Cell Biochem. 2010 Jan;333(1-2):129-35. doi: 10.1007/s11010-009-0213-3. Epub 2009 Jul 21.

DOI:10.1007/s11010-009-0213-3
PMID:19629645
Abstract

Here, cluster analysis showed that a database of 158 anticancer peptides formed 21 clusters based on net positive charge, hydrophobicity and amphiphilicity. In general, these clusters showed similar median toxicities (P = 0.176) against eukaryotic cell lines and no single combination of these properties was found optimal for efficacy. The database contained 14 peptides, which showed selectivity for tumour cell lines only (ACP(CT)), 123 peptides with general toxicity to eukaryotic cells (ACP(GT)) and 21 inactive peptides (ACP(I)). Hydrophobic arc size analysis showed that there was no significant difference across the datasets although peptides with wide hydrophobic arcs (>270 degrees) appeared to be associated with decreased toxicity. Extended hydrophobic moment plot analysis predicted that over 50% of ACP(CT) and ACP(GT) peptides would be surface active, which led to the suggestion that amphiphilicity is a key driver of the membrane interactions for these peptides but probably plays a role in their efficacy rather than their selectivity. This analysis also predicted that only 14% of ACP(CT) peptides compared to 45% of ACP(GT) peptides were candidates for tilted peptide formation, which led to the suggestion that the absence of this structure may support cancer cell selectivity. However, these analyses predicted that ACP(I) peptides, which possess no anticancer activity, would also form surface active and tilted alpha-helices, clearly showing that other factors are involved in determining the efficacy and selectivity of ACPs.

摘要

在这里,聚类分析显示,基于净正电荷、疏水性和两亲性,一个包含 158 种抗癌肽的数据库形成了 21 个簇。一般来说,这些簇表现出对真核细胞系相似的中位毒性(P=0.176),并且没有发现这些特性的单一组合对疗效最优。该数据库包含 14 种仅对肿瘤细胞系显示选择性的肽(ACP(CT))、123 种对真核细胞具有一般毒性的肽(ACP(GT))和 21 种无活性肽(ACP(I))。疏水性弧形大小分析表明,虽然具有宽疏水性弧形(>270 度)的肽似乎与毒性降低有关,但在整个数据集之间没有显著差异。扩展的疏水性矩图分析预测,超过 50%的 ACP(CT)和 ACP(GT)肽将具有表面活性,这表明两亲性是这些肽与膜相互作用的关键驱动因素,但可能在其疗效而非选择性中发挥作用。该分析还预测,只有 14%的 ACP(CT)肽,而不是 45%的 ACP(GT)肽,是倾斜肽形成的候选者,这表明缺乏这种结构可能支持癌细胞的选择性。然而,这些分析预测,没有抗癌活性的 ACP(I)肽也将形成具有表面活性和倾斜的α-螺旋,这清楚地表明,其他因素也参与了确定 ACP 的疗效和选择性。

相似文献

1
A theoretical analysis of secondary structural characteristics of anticancer peptides.抗癌肽二级结构特征的理论分析。
Mol Cell Biochem. 2010 Jan;333(1-2):129-35. doi: 10.1007/s11010-009-0213-3. Epub 2009 Jul 21.
2
On the selectivity and efficacy of defense peptides with respect to cancer cells.关于防御肽对癌细胞的选择性和功效。
Med Res Rev. 2013 Jan;33(1):190-234. doi: 10.1002/med.20252. Epub 2011 Sep 15.
3
ACP-CapsPred: an explainable computational framework for identification and functional prediction of anticancer peptides based on capsule network.ACP-CapsPred:一种基于胶囊网络的用于识别和抗癌肽功能预测的可解释计算框架。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae460.
4
ACP-MHCNN: an accurate multi-headed deep-convolutional neural network to predict anticancer peptides.ACP-MHCNN:一种准确的多头深度卷积神经网络,用于预测抗癌肽。
Sci Rep. 2021 Dec 8;11(1):23676. doi: 10.1038/s41598-021-02703-3.
5
ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides.ACPred:一种用于抗癌肽预测和分析的计算工具。
Molecules. 2019 May 22;24(10):1973. doi: 10.3390/molecules24101973.
6
Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides.基于肽的 3D 结构的混合模型预测高效低毒的抗癌肽。
Int J Mol Sci. 2021 May 26;22(11):5630. doi: 10.3390/ijms22115630.
7
PLMACPred prediction of anticancer peptides based on protein language model and wavelet denoising transformation.基于蛋白质语言模型和小波去噪变换的抗癌肽 PLMACPred 预测。
Sci Rep. 2024 Jul 23;14(1):16992. doi: 10.1038/s41598-024-67433-8.
8
Effective identification and differential analysis of anticancer peptides.有效鉴定与差异分析抗癌肽。
Biosystems. 2024 Jul;241:105246. doi: 10.1016/j.biosystems.2024.105246. Epub 2024 Jun 5.
9
CancerPPD: a database of anticancer peptides and proteins.CancerPPD:抗癌肽和蛋白质数据库。
Nucleic Acids Res. 2015 Jan;43(Database issue):D837-43. doi: 10.1093/nar/gku892. Epub 2014 Sep 30.
10
Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.抗癌α-螺旋肽及其与肿瘤细胞膜相互作用的结构/功能关系。
Curr Protein Pept Sci. 2006 Dec;7(6):487-99. doi: 10.2174/138920306779025611.

引用本文的文献

1
The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures.抗菌肽对细菌和癌细胞的双重作用;纳米结构的作用机制和治疗策略。
Microb Cell Fact. 2022 Jun 18;21(1):118. doi: 10.1186/s12934-022-01848-8.
2
Peptides with Dual Antimicrobial-Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides.具有双重抗菌-抗癌活性的肽:克服肽局限性的策略和抗癌肽的合理设计。
Molecules. 2020 Sep 16;25(18):4245. doi: 10.3390/molecules25184245.
3
Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).

本文引用的文献

1
Relationships between the orientation and the structural properties of peptides and their membrane interactions.肽的取向与其结构性质及其膜相互作用之间的关系。
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1537-44. doi: 10.1016/j.bbamem.2008.04.006. Epub 2008 Apr 25.
2
Studies on anticancer activities of antimicrobial peptides.抗菌肽的抗癌活性研究。
Biochim Biophys Acta. 2008 Feb;1778(2):357-75. doi: 10.1016/j.bbamem.2007.11.008. Epub 2007 Nov 22.
3
Tilted peptides: a structural motif involved in protein membrane insertion?
抗癌肽:理化性质、功能方面及临床应用趋势(综述)。
Int J Oncol. 2020 Sep;57(3):678-696. doi: 10.3892/ijo.2020.5099. Epub 2020 Jul 10.
4
In silico design and optimization of selective membranolytic anticancer peptides.计算机辅助设计和优化选择性膜溶抗肿瘤肽。
Sci Rep. 2019 Aug 2;9(1):11282. doi: 10.1038/s41598-019-47568-9.
5
Peptides with Dual Antimicrobial and Anticancer Activities.具有双重抗菌和抗癌活性的肽。
Front Chem. 2017 Feb 21;5:5. doi: 10.3389/fchem.2017.00005. eCollection 2017.
6
The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach.对肽Trichogin GA IV的选择性抗癌衍生物的合理探索:一种多技术生物物理方法。
Sci Rep. 2016 Apr 4;6:24000. doi: 10.1038/srep24000.
7
The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs.人源杀菌肽LL-37及其模拟物是潜在的抗癌药物。
Front Oncol. 2015 Jun 30;5:144. doi: 10.3389/fonc.2015.00144. eCollection 2015.
8
Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.人乳铁蛋白衍生肽杀死黑色素瘤细胞及其转移灶需要与癌症标志物磷脂酰丝氨酸相互作用。
Biometals. 2014 Oct;27(5):981-97. doi: 10.1007/s10534-014-9749-0. Epub 2014 May 18.
9
Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.膜活性宿主防御肽——新型抗癌药物开发的挑战与展望。
Chem Phys Lipids. 2011 Nov;164(8):766-81. doi: 10.1016/j.chemphyslip.2011.09.004. Epub 2011 Sep 16.
倾斜肽段:一种参与蛋白质膜插入的结构基序?
J Pept Sci. 2008 Apr;14(4):416-22. doi: 10.1002/psc.971.
4
The interactions of aurein 1.2 with cancer cell membranes.奥瑞因1.2与癌细胞膜的相互作用。
Biophys Chem. 2007 Apr;127(1-2):78-83. doi: 10.1016/j.bpc.2006.12.009. Epub 2006 Dec 22.
5
Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.抗癌α-螺旋肽及其与肿瘤细胞膜相互作用的结构/功能关系。
Curr Protein Pept Sci. 2006 Dec;7(6):487-99. doi: 10.2174/138920306779025611.
6
Host defense peptides as new weapons in cancer treatment.宿主防御肽作为癌症治疗的新武器。
Cell Mol Life Sci. 2005 Apr;62(7-8):784-90. doi: 10.1007/s00018-005-4560-2.
7
Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion?抗菌肽是否利用倾斜取向的α螺旋进行膜入侵?
Protein Pept Lett. 2005 Jan;12(1):27-9. doi: 10.2174/0929866053406039.
8
Membrane disrupting lytic peptides for cancer treatments.用于癌症治疗的膜破坏溶细胞肽。
Curr Pharm Des. 2004;10(19):2299-310. doi: 10.2174/1381612043383971.
9
Interaction of antimicrobial peptides from Australian amphibians with lipid membranes.澳大利亚两栖动物抗菌肽与脂质膜的相互作用。
Chem Phys Lipids. 2003 Jan;122(1-2):107-20. doi: 10.1016/s0009-3084(02)00182-2.
10
Use of hydrophobic moment plot methodology to aid the identification of oblique orientated alpha-helices.
Mol Membr Biol. 2000 Oct-Dec;17(4):201-7. doi: 10.1080/09687680010018826.